Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 897
Filter
1.
J. Health Biol. Sci. (Online) ; 10(1): 1-5, 01/jan./2022. tab
Article in English | LILACS | ID: biblio-1411586

ABSTRACT

Objective: To understand the demands caused by chikungunya in the chronic phase and their impacts on patients' mental health and quality of life. Materials and methods: This is a qualitative study, performed from November 2019 to January 2020. Focus groups and deep interviews were carried out. Then, the Discourse Analysis was performed. Results: Chronic pain was the main clinical manifestation reported by the participants, being responsible for affecting aspects related to quality of life and mental health. As for psycological view, this study showed that chronic pain was also reported as one of the main symptoms related to anxiety and depression among research subjects. Conclusion: this study demonstrated how the chronic illness caused by Chikungunya impacted the subjects' perception in the domains related to quality of life and mental health. Furthermore, we seek to focus on the management of disease in a holistic way, putting the patients' own awareness of the impacts of the disease on their lives in a relevant level of their treatment.


Objetivo: Compreender as demandas causadas pela chikungunya em sua fase crônica e seus impactos na saúde mental e na qualidade de vida dos pacientes. Métodos: Trata-se de um estudo com abordagem qualitativa, realizado entre novembro de 2019 a janeiro de 2020. Inicialmetne, foram realizados grupos focais e entrevistas em profundidade; seguidas da Análise do Discurso. Resultados: A dor crônica foi a principal manifestação clínica relatada pelos participantes, sendo responsável por afetar aspectos relacionados à qualidade de vida e saúde mental. Quanto ao aspecto psicológico, este estudo mostrou que a dor crônica também foi relatada como um dos principais sintomas relacionados à ansiedade e depressão entre os sujeitos da pesquisa. Conclusão: este estudo demonstrou como a doença crônica causada pela chikungunya impactou na percepção dos sujeitos em seus domínios relacionados à qualidade de vida e saúde mental. Além disso, procuramos centrar-nos na gestão da doença de forma holística, colocando a consciência dos próprios doentes sobre os impactos da doença nas suas vidas num nível relevante do seu tratamento.


Subject(s)
Chikungunya Fever , Patients , Quality of Life , Signs and Symptoms , Therapeutics , Public Health , Focus Groups , Disease Management , Chronic Pain
2.
Rev. cuba. hematol. inmunol. hemoter ; 38(2): e1503, abr.-jun. 2022. tab
Article in Spanish | LILACS, CUMED | ID: biblio-1408449

ABSTRACT

Introducción: La hemofilia es un trastorno hemorrágico que causa dolor y daños articulares graves. Las personas con esta condición de salud suelen presentar problemas psicosociales como baja autoestima y dificultad para enfrentar la enfermedad, lo cual puede impactar negativamente en su calidad de vida relacionada a la salud (CVRS). Objetivo: Analizar el efecto predictor de la autoestima y las estrategias de afrontamiento hacia la CVRS en personas con hemofilia. Métodos: Estudio cuantitativo, no experimental, de tipo correlacional, con muestra por conveniencia, realizado en 60 participantes con hemofilia, edades comprendidas entre 15 y 67 años (media = 27,43, desviación estándar = 11,32). Se utilizaron los cuestionarios: Calidad de Vida Específica para Hemofilia, Autoestima y Afrontamiento al Dolor Crónico. Se realizaron análisis descriptivos, correlación de Pearson y análisis de regresión lineal múltiple con el método por pasos. Resultados: Se obtuvo que el nivel de CVRS fue mayormente moderado; sin embargo, se observaron niveles bajos en las dimensiones Deporte y tiempo libre y Futuro. La dimensión Éxito de la escala de autoestima correlacionó positivamente con las dimensiones Deporte y tiempo libre (r(60)= 0,59), Salud física (r(60)=0,54) y Autopercepción (r(60)=0,48) de la escala calidad de vida; además de haber mostrado un nivel alto de predicción de la calidad de vida (R 2 = 0,35, p= 0,00). Conclusiones: Se comprobó que la autoestima resulta ser una variable predictora de la CVRS de los pacientes con hemofilia. Se requiere fortalecer la autoestima y la manera de enfrentarse ante el dolor crónico en personas con este padecimiento en pro de su calidad de vida y bienestar(AU)


Introduction: Hemophilia is a bleeding disorder that causes severe pain and damage to the joints. People with this health condition often present psychosocial problems such as low self-esteem and difficulty facing their disease, which can negatively impact their health-related quality of life (HRQoL). Objective: To analyze the predictive effect of self-esteem and coping strategies towards HRQL in people with hemophilia. Methods: This was a quantitative, non-experimental, correlational study, with a convenience sample, carried out in 60 participants with hemophilia, ages between 15 and 67 years (mean = 27.43, standard deviation = 11.32). The Specific Quality of Life for Hemophilia, Self-esteem and Coping with Chronic Pain questionnaires were used. Descriptive analyzes. Pearson correlation and multiple linear regression analysis were performed with the stepwise method. Results: It was found that the level of HRQL was mostly moderate, however, low levels were observed in the Sports and free time and Future dimensions. The Success dimension of the self-esteem scale positively correlated with the Sports and free time dimensions (r(60) = 0.59). Physical health (r(60) = 0.54) and Self-perception (r(60) = 0.48) of the quality of life scale, in addition to having shown a high level of prediction of quality of life (R2 = 0.35, p = 0.00). Conclusions: It was found that self-esteem turns out to be a predictor variable of HRQL in patients with hemophilia. It is necessary to strengthen self-esteem and the way of coping with chronic pain in people with this condition in favor of their quality of life and well-being(AU)


Subject(s)
Humans , Male , Quality of Life , Adaptation, Psychological , Regression Analysis , Chronic Pain , Hemophilia A , Surveys and Questionnaires
3.
Article in Spanish | LILACS, BNUY, UY-BNMED | ID: biblio-1383556

ABSTRACT

Introducción: Se describe la evolución de un paciente que recibe morfina intratecal mediante una bomba de infusión, que le fuera implantada hace 14 años para tratamiento de su dolor lumbar crónico post-laminectomía. Material y método: Requería la administración de 60 mg/día de morfina subcutánea que le provocaban efectos secundarios que no toleraba, y múltiples internaciones para control del dolor. Se le implantó una bomba de infusión continua (Isomed) conectada a un catéter subaracnoideo, que libera 1 ml/día, y requiere ser llenada cada 60 días. Resultados: Se observó una disminución del dolor promedio de 50% al año, y de 75% a los 6 y 14 años. Requirió un aumento progresivo de las dosis de llenado, que pasaron de 30 mg de morfina (0.5 mg/día) al inicio, a 40 mg de morfina (0.66 mg /día) al año, a 70 mg de morfina (1.16 mg/día) a los 6 años, a 140 mg (2.33 mg/día) a los 14 años. No se registraron complicaciones médicas graves. Mantuvo constipación y sudoración durante todo el período, e instaló un hipogonadismo secundario con trastornos de la libido y de la erección que fueron corregidos con la administración de testosterona. No requirió más internaciones por dolor. No se observaron complicaciones relacionadas con el funcionamiento o llenado de la bomba, ni vinculadas al catéter. El paciente manifestó estar satisfecho con el implante. Discusión: A pesar del aumento de las dosis de llenado, expresión del desarrollo de tolerancia, las dosis de morfina/día requeridas son francamente inferiores al límite recomendado. Conclusiones: El balance del riesgo-beneficio del implante resultó positivo, considerando el mejor control del dolor logrado, las menores dosis de morfina utilizadas, así como la ausencia de complicaciones graves y de internaciones para control del dolor.


Introduction: The evolution of a patient receiving intrathecal morphine through an infusion pump that was implanted 14 years ago for the treatment of chronic post-laminectomy low back pain is described. Material and method: It required the administration of 60 mg / day of subcutaneous morphine that caused side effects that did not tolerate, and multiple hospitalizations for pain control. He was implanted with a continuous infusion pump (Isomed) connected to a subarachnoid catheter, which releases 1 ml / day, and needs to be filled every 60 days. Results: An average pain decrease of 50% per year, and 75% at 6 and 12 years was observed. It required a progressive increase in filling doses, which went from 30 mg of morphine (0.5 mg / day) at the beginning, to 40 mg of morphine (0.66 mg / day at the first year, to 70 mg of morphine (1.16 mg / day) at the sixth year, at 140 mg (2.33 mg / day) at the fourteen year. No serious medical complications were recorded, he maintained constipation and sweating throughout the period, and installed secondary hypogonadism with libido and erection disorders, that were corrected with the administration of testosterone. No further hospitalizations were required due to pain. No complications were observed related to the operation or filling of the pump or linked to the catheter. The patient stated that he was satisfied with the implant. Discussion: Despite the increase in filling doses, expression of tolerance development, the required morphine / day doses are frankly below the recommended limit. Conclusions: The risk-benefit balance of the implant was positive, considering the best pain control, the lowest doses used, the absence of serious complications, and the lack of hospitalizations for pain control.


Introdução: Descreve-se a evolução de um paciente que recebeu morfina intratecal através de uma bomba de infusão, implantada há 14 anos para o tratamento de lombalgia crônica pós-laminectomia. Material e método: Necessitou de administração de 60 mg/dia de morfina por via subcutânea, que provocou efeitos colaterais intolerantes, e múltiplas internações para controle da dor. Foi implantada uma bomba de infusão contínua (Isomed) conectada a um cateter subaracnóideo, que libera 1 ml/dia, necessitando de reenchimento a cada 60 dias. Resultados: Observou-se redução média da dor de 50% em um ano e 75% em 6 e 14 anos. Foi necessário um aumento progressivo das doses de enchimento, que passaram de 30 mg de morfina (0,5 mg/dia) no início, para 40 mg de morfina (0,66 mg/dia) por ano, para 70 mg de morfina (1,16 mg/dia) dia) aos 6 anos, para 140 mg (2,33 mg/dia) aos 14 anos. Não foram registradas complicações médicas graves. Manteve constipação e sudorese durante todo o período e desenvolveu hipogonadismo secundário com distúrbios de libido e ereção que foram corrigidos com administração de testosterona. Ele não necessitou de mais hospitalizações por dor. Não foram observadas complicações relacionadas à operação ou enchimento da bomba, ou relacionadas ao cateter. O paciente afirmou estar satisfeito com o implante. Discussão: Apesar do aumento das doses de enchimento, expressão do desenvolvimento da tolerância, as doses necessárias de morfina/dia são francamente inferiores ao limite recomendado. Conclusões: A relação risco-benefício do implante foi positiva, considerando o melhor controle da dor alcançado, as menores doses de morfina utilizadas, bem como a ausência de complicações graves e internações para controle da dor.


Subject(s)
Humans , Male , Aged , Infusion Pumps, Implantable , Low Back Pain/drug therapy , Analgesics, Opioid/administration & dosage , Morphine/administration & dosage , Pain Measurement , Injections, Spinal , Treatment Outcome , Risk Assessment , Catheters , Chronic Pain/drug therapy , Analgesics, Opioid/adverse effects , Morphine/adverse effects
4.
Medicina (Ribeirao Preto, Online) ; 55(1)maio 2022. ilus, tab
Article in Portuguese | LILACS | ID: biblio-1410579

ABSTRACT

Introdução: Hipofosfatasia é um distúrbio metabólico que afeta a mineralização óssea e dentária, causada por mutações no gene ALPL, levando à deficiência enzimática da fosfatase alcalina tecido não-específica. A forma adulta caracteriza-se por fraturas atípicas do fêmur, osteomalácia, osteoporose, grave osteoartropatia, condrocalcinose e artralgia. Objetivo: Demonstrar desafios diagnósticos relacionados à hipofosfatasia através do relato de dois casos. Paciente 1: feminino, 59 anos, encaminhada para avaliação clínica devido às fraturas patológicas de difícil consolidação e osteoporose generalizada de causa genética. Relata perda dentária precoce da arcada superior, fraturas na coluna, em ombro esquerdo e no fêmur. Atualmente, queixa-se de dor crônica intensa, com uso de múltiplos medicamentos. Achados clínicos, laboratoriais e radiológicos foram compatíveis com o diagnóstico de hipofosfatasia. Paciente 2: masculino, 31 anos, filho da paciente 1, encaminhado para avaliação clínica por fratura patológica precoce em fêmur esquerdo e osteoporose não esclarecida. Atualmente relata dor e claudicação importante em membro inferior esquerdo, associado à lombalgia crônica. Confirmação do diagnóstico de hipofosfatasia por exames laboratoriais e radiológicos e sequenciamento do gene ALPL, aliados ao diagnóstico da sua genitora. Discussão: Hipofosfatasia é uma doença rara de herança autossômica dominante e recessiva. Pacientes acometidos apresentam fraturas constantes, densidade mineral óssea baixa, cicatrização óssea deficitária. É comum a hipofosfatasia ser diagnosticada erroneamente como osteopenia e/ou osteoporose primária, acarretando prejuízos ao paciente. Ressalta-se a importância da história clínica completa e dos antecedentes familiares a fim de se obter um diagnóstico precoce, garantindo, por sua vez, o adequado acompanhamento e manejo terapêutico (AU)


Introduction: hypophosphatasia is a metabolic disorder affecting bone and tooth mineralization, caused by mutations in the ALPL gene leading to enzymatic deficiency of tissue non-specific alkaline phosphatase. The adult form is characterized by atypical femur fractures, osteomalacia, osteoporosis, severe osteoarthropathy, chondrocalcinosis, and arthralgia. Objective: to demonstrate diagnostic challenges related to hypophosphatasia through the report of two cases. Patient 1: female, 59 years old, referred for clinical evaluation due to pathological fractures of difficult consolidation and generalized osteoporosis of genetic cause. She reports early tooth loss in the upper arch, fractures in the spine, left shoulder and femur. Currently, he complains of severe chronic pain, with use of multiple medications. Clinical, laboratory, and radiological findings were compatible with the diagnosis of hypophosphatasia. Patient 2:male, 31 years old, son of patient 1, referred for clinical evaluation due to an early pathological fracture in the left femur and unclear osteoporosis. He currently reports pain and significant claudication in the left lower limb, associated with chronic low back pain. Confirmation of the diagnosis of hypophasatasia by laboratory and radiological tests and sequencing of the ALPL gene combined with the diagnosis of his mother. Discussion: hypophosphatasia is a rare disease of autosomal dominant and recessive inheritance. Affected patients have constant fractures, low bone mineral density, and impaired bone healing. It is common for hypophosphatasia to be misdiagnosed as osteopenia and/or primary osteoporosis, which can be harmful to the patient. The importance of a complete clinical history and family history is emphasized in order to obtain an early diagnosis, ensuring adequate follow-up and therapeutic management (AU)


Subject(s)
Humans , Male , Female , Adult , Middle Aged , Osteoporosis , Bone Diseases, Metabolic , Alkaline Phosphatase , Chronic Pain , Fractures, Spontaneous , Hypophosphatasia/diagnosis
5.
ABCS health sci ; 47: e022220, 06 abr. 2022. tab, graf
Article in English | LILACS | ID: biblio-1398268

ABSTRACT

Introduction: The presence of chronic pain and mood disorders can be related to the performance of intellectual and technical tasks. Objective: This study evaluated the correlation between anxiety level, chronic orofacial pain of temporomandibular disorders (TMD), and academic performance in dental students. Methods: One hundred ninety-five students (74 men and 121 women) answered the Spielberger's trait­state anxiety inventory to evaluate the level of anxiety; the Research Diagnostic Criteria for TMD (RDC/TMD) was used to analyze chronic orofacial pain of TMD, and the academic performance was evaluated through the average grade of all college subjects concluded by the students. Correlations between the presence of chronic orofacial pain of TMD, trait, and state anxiety levels, chronic pain grade (CPG), chronic pain intensity (CPI), and academic performance were tested using Pearson's correlation test. Results: The mean age of the students was 21.8 years (SD=2.3). Chronic TMD was observed in 37.5% of the students. The majority of students had moderate trait and state anxiety. A significant correlation was observed between traitanxiety level and CPG (r=0.148, p=0.044), and CPI (r=0.187, p=0.009). No significant correlation was found between academic grade and presence of chronic pain of TMD (r=0.041, p=0.571), trait (r=0.079, p=0.273) and state-anxiety (r=0.107, p=0.136). Conclusion: The CPG and CPI increase in participants with higher trait-anxiety levels, however, no significant correlation was found between academic performance and trait/state anxiety or chronic orofacial pain of TMD.


Subject(s)
Humans , Male , Female , Adult , Young Adult , Anxiety , Students, Dental , Temporomandibular Joint Dysfunction Syndrome , Chronic Pain , Academic Performance , Universities , Cross-Sectional Studies
6.
Invest. educ. enferm ; 40(1): 115-128, 01/03/2022. tab
Article in English | LILACS, BDENF, COLNAL | ID: biblio-1370185

ABSTRACT

Objective. To examine the prevalence of chronic pain and the associated factors among nursing students. Methods. This study is a descriptive, cross-sectional. The subjects were 1684 nursing students who were selected from the universities of medical sciences in Iran via cluster sampling in 2019. Data were collected using a three-part questionnaire: a demographic characteristics survey, characteristics of chronic pain, and a pain scale. Results. The majority of the students were female (62.1%) and single (87%).The mean age of the participants was 22.4±2.96 years. The results of data analysis showed that 30.2% of the students suffered from chronic pain. The areas which were most affected by pain were: head (31.24%), abdomen (11.98%), and the back (9.23%). 56.4% of the nursing students declared the origin of their pain to be unknown, 22.7% attributed their pain to migraine, and 6.48% reported spinal disorders to be the cause of their pain. There was a significant relationship between the students' chronic pain and the variables of age (higher in the 29-and-above age group), marital status (higher in married subjects), and education (higher in postgraduates). Conclusion. A relatively large number of nursing students suffer from chronic pains. Nursing schools should contribute to improving students' knowledge of chronic pain prevention and management.


Objetivo. Estimar la prevalencia del dolor crónico y sus factores asociados entre los estudiantes de enfermería. Métodos. Estudio descriptivo de corte transversal. Participaron 1684 estudiantes de enfermería (1496 de pregrado y 188 de Maestría) de las universidades de ciencias médicas en Irán seleccionados mediante un muestreo por conglomerados. Los datos se recogieron a partir de un cuestionario dividido en tres partes: una encuesta de características demográficas, características del dolor crónico y una escala de dolor. Resultados. La mayoría de los estudiantes fueron de sexo femenino (62.1%) y solteros (87%). La edad media fue de 22.4±2.9 años. Los resultados del análisis de los datos mostraron que el 30.2% de los estudiantes sufría dolor crónico. Las zonas más afectadas por el dolor fueron: la cabeza (31.24%), el abdomen (11.98%) y la espalda (9.23%). El origen del dolor fue más frecuentemente atribuido a la migraña (22.7%) y a los trastornos de la columna vertebral (6.5%). Un 56.4% declaró desconocer el origen de su dolor. Hubo una relación significativa entre el dolor crónico de los estudiantes y las variables: edad (mayor en el grupo de 29 años o más), estado civil (mayor en los casados), educación (mayor en los estudiantes de maestría). Conclusión. Un número relativamente elevado de estudiantes de enfermería sufre de dolores crónicos. Las escuelas de enfermería deben contribuir en mejorar el conocimiento de ellos acerca de la prevención y manejo del dolor crónico.


Objetivo. Estimar a prevalência da dor crónica e seus fatores associados entre os estudantes de enfermagem. Métodos. Estudo descritivo de corte transversal. Os participantes foram 1684 estudantes de enfermagem (1496 de graduação e 188 de Mestrado) das universidades de ciências médicas no Irã que foram selecionados através de uma amostragem por conglomerados. Os dados se recolheram mediante um questionário dividido em três partes: uma enquete de características demográficas, características da dor crónica e uma escala de dor. Resultados. A maioria dos estudantes foram do sexo feminino (62.1%) e solteiros (87%). A idade média dos participantes foi de 22.4±2.9 anos. Os resultados da análise dos dados mostraram que 30.2% dos estudantes sofriam dor crónica. As zonas mais afetadas pela dor foram: a cabeça (31.24%), o abdômen (11.98%) e as costas (9.23%). A origem da dor foi mais frequentemente atribuída à enxaqueca (22.7%) e aos transtornos da coluna vertebral (6.5%). Um 56.4% dos estudantes de enfermagem declararam desconhecer a origem da sua dor. Houve uma relação significativa entre a dor crónica dos estudantes e as variáveis: idade (maior no grupo de 29 anos ou mais), estado civil (maior nos casados), educação (maior nos estudantes de mestrado). Conclusão. Um número relativamente elevado de estudantes de enfermagem sofre de dores crónicas. As escolas de enfermagem devem contribuir em melhorar o conhecimento dos estudantes sobre a prevenção e manejo da dor crónica.


Subject(s)
Students, Nursing , Cross-Sectional Studies , Chronic Pain
7.
Rev. Assoc. Med. Bras. (1992) ; 68(1): 56-60, Jan. 2022. tab
Article in English | LILACS | ID: biblio-1360702

ABSTRACT

SUMMARY OBJECTIVE: The objective of this study was to measure the intra- and inter-rater reliability of the quantitative sensory testing for measuring the thermal pain threshold on myofascial trigger points in the upper trapezius muscle of individuals with chronic neck pain. METHODS: Thirty female participants were included, aged between 18 and 45 years and with bilateral myofascial trigger points, active and centrally located in the upper trapezius muscle. Two measurements with quantitative sensory testing were performed by each examiner at an interval of 1 week between them. RESULTS: We observed substantial reliability for the intra-rater analysis (intraclass correlation coefficient ranging between 0.876 and 0.896) and excellent reliability for the inter-rater analysis (intraclass correlation coefficient ranging between 0.917 and 0.954). CONCLUSION: The measurement of the thermal pain threshold on myofascial trigger points in individuals with chronic neck pain has acceptable reliability values, supporting the use of the quantitative sensory testing in the research setting and the clinical environment.


Subject(s)
Humans , Female , Adolescent , Adult , Young Adult , Neck Pain/epidemiology , Trigger Points/physiopathology , Superficial Back Muscles/physiopathology , Myofascial Pain Syndromes/diagnosis , Myofascial Pain Syndromes/physiopathology , Reproducibility of Results , Chronic Pain , Middle Aged
8.
Esc. Anna Nery Rev. Enferm ; 26(spe): e20210351, 2022. tab
Article in Portuguese | LILACS, BDENF | ID: biblio-1392334

ABSTRACT

Objetivos: Identificar as manifestações de dor crônica (DC), ansiedade e sintomas depressivos em estudantes de Enfermagem de uma universidade pública federal em tempos de pandemia, analisando a associação entre essas variáveis, e descrever as características sociodemográficas e de hábitos de vida na população estudada. Método: Estudo quantitativo, transversal, observacional e analítico, realizado de julho a novembro de 2020, com amostra de 119 estudantes de Enfermagem matriculados no segundo semestre de 2020. Foram utilizados questionários para caracterização sociodemográfica e de hábitos de vida, o mapa corporal da Escala Multidimensional de Avaliação de Dor, o Inventário de Ansiedade Traço-Estado e o Patient Health Questionnaire-9. Resultados: A maioria dos estudantes de Enfermagem da amostra é do sexo feminino, com idade média de 23,4 anos, e 37,8% convivem com DC. Os estudantes com DC apresentaram maiores níveis de ansiedade e mais sintomas depressivos. Verificou-se associação entre DC, ansiedade e sintomas depressivos nessa amostra. Conclusão: Durante o período pandêmico investigado, foi encontrada associação entre DC, ansiedade e sintomas depressivos na população de estudantes de Enfermagem da universidade investigada, indicando que os acadêmicos com DC experimentam maiores níveis de ansiedade e mais sintomas depressivos do que aqueles sem DC


Objectives: To identify the manifestations of chronic pain (CP), anxiety, and depressive symptoms in nursing students at a federal public university in pandemic times, analyzing the association between these variables and to describe population characteristics. Method: This was a quantitative, cross-sectional, observational, and analytical study carried out from July to November 2020 with a sample of 119 nursing students enrolled in the second half of 2020. Questionnaires were used to characterize sociodemographic and lifestyle habits, the body map of the Multidimensional Pain Evaluation Scale, the State-Trait Anxiety Inventory, and the Patient Health Questionnaire-9. Results: Nursing students in the studied sample are mostly female, with a mean age of 23.4 years, and 37.8% live with CP. Students with CP had higher anxiety levels and more depressive symptoms. There was an association between PC, anxiety, and depressive symptoms in this sample. Conclusion: During the pandemic period investigated, an association was found between PC, anxiety, and depressive symptoms in the population of nursing students at the studied university, indicating that those who live with PC experience higher anxiety levels and more depressive symptoms than students without PC


Objetivos: Identificar las manifestaciones de dolor crónico (DC), ansiedad y síntomas depresivos en estudiantes de enfermería de una universidad pública federal en tiempos de pandemia, analizando la asociación entre estas variables; y describir las características de la población. Método: Estudio cuantitativo, transversal, observacional y analítico, realizado de julio a noviembre de 2020, con una muestra de 119 estudiantes de enfermería matriculados en el segundo semestre de 2020. Se utilizaron cuestionarios para caracterizar hábitos sociodemográficos y de estilo de vida: el mapa corporal de la Escala Multidimensional de Evaluación del Dolor, el Inventario de Ansiedad Rasgo-Estado y el Patient Health Questionnaire-9. Resultados: La mayoría de los estudiantes de enfermería de la muestra estudiada son mujeres, con una edad media de 23,4 años, y el 37,8% vive con DC. Los estudiantes con DC tenían niveles más altos de ansiedad y más síntomas depresivos. Hubo una asociación entre DC, ansiedad y síntomas depresivos en esta muestra. Conclusión: Durante el período pandémico investigado, se encontró asociación entre DC, ansiedad y síntomas depresivos en la población de estudiantes de Enfermería de la universidad estudiada, señalando que quienes viven con DC experimentan mayores niveles de ansiedad y más síntomas depresivos que los estudiantes sin DC


Subject(s)
Humans , Male , Female , Adult , Middle Aged , Young Adult , Anxiety , Students, Nursing/psychology , Mental Health , Depression , Chronic Pain , COVID-19 , Socioeconomic Factors , Pain Measurement/statistics & numerical data , Cross-Sectional Studies
10.
Rev. Esc. Enferm. USP ; 56(spe): e20210450, 2022. tab, graf
Article in English, Portuguese | LILACS, BDENF | ID: biblio-1387311

ABSTRACT

ABSTRACT Objective: To test the effects of a brief interprofessional intervention for chronic pain management. Methods: Before and after pilot study. The brief interprofessional intervention had a psychoeducational focus and was based on the Self-Efficacy Theory, using Cognitive-Behavioral Therapy strategies. The intervention aimed to improve the management of chronic pain. It was conducted in group, over six weeks, with a two-hour weekly meeting, including educational strategies on pain management, stretching, and relaxation techniques. Self-efficacy, pain intensity, disability, fatigue, and depressive symptoms were assessed. Data were analyzed using the paired t-test and Pearson's correlation. Results: Adults with moderate to severe pain took part in the study. Post-intervention analysis showed significant improvement in self-efficacy (p = 0.004) and significant reduction in pain intensity (p = 0.024), disability (p = 0.012), fatigue (p = 0.001), and depressive symptoms (p = 0.042). Conclusion: The effects of brief interprofessional intervention were positive for chronic pain management. We suggest the conduction of studies with more robust designs and a larger sample to confirm these findings.


RESUMEN Objetivo: Probar los efectos de una breve intervención interprofesional en el manejo del dolor crónico. Método: Estudio piloto, de tipo antes y después. La breve intervención interprofesional, de enfoque psicoeducativo, estuvo basada en la Teoría de la Autoeficacia, con el uso de estrategias de Terapia Cognitivo-Conductual. La intervención tuvo como propósito mejorar el manejo del dolor crónico. Se realizó en grupo durante seis semanas, con una reunión semanal de dos horas, incluidas estrategias educativas sobre el manejo del dolor, estiramiento y técnicas de relajación. Se evaluaron la autoeficacia, la intensidad del dolor, la discapacidad, la fatiga y los síntomas depresivos. Los datos se analizaron utilizando la prueba t pareada y la correlación de Pearson. Resultados: En el estudio participaron adultos con dolor de moderado a severo. El análisis posintervención apuntó a una mejora significativa en la autoeficacia (p = 0,004) y una significativa reducción en la intensidad del dolor (p = 0,024), discapacidad (p = 0,012), fatiga (p = 0,001) y síntomas depresivos (p = 0,042). Conclusión: Los efectos de la breve intervención interprofesional fueron positivos en el manejo del dolor crónico. Se sugieren estudios con diseños más robustos y una muestra más grande para confirmar estos hallazgos.


RESUMO Objetivo: Testar os efeitos de uma intervenção interprofissional breve para manejo da dor crônica. Método: Estudo piloto do tipo antes e depois. A intervenção interprofissional breve teve enfoque psicoeducativo e foi baseada na Teoria da Autoeficácia, com utilização de estratégias da Terapia Cognitivo-Comportamental. A finalidade da intervenção foi melhorar o manejo da dor crônica. Realizada em grupo, ao longo de seis semanas, com um encontro semanal de duas horas, incluindo estratégias educativas sobre manejo da dor, alongamento e técnicas de relaxamento. Autoeficácia, intensidade da dor, incapacidade, fadiga e sintomas depressivos foram avaliados. Os dados foram analisados por meio do teste t-pareado e correlação de Pearson. Resultados: Participaram do estudo adultos com dor moderada a intensa. A análise pós-intervenção mostrou melhora significativa da autoeficácia (p = 0,004) e redução significativa da intensidade da dor (p = 0,024), incapacidade (p = 0,012), fadiga (p = 0,001) e sintomas depressivos (p = 0,042). Conclusão: Os efeitos da intervenção interprofissional breve foram positivos para manejo da dor crônica. Sugere-se estudos com desenhos mais robustos e amostra ampliada para confirmar estes achados.


Subject(s)
Chronic Pain , Pain Management , Cognitive Behavioral Therapy , Health Education , Self Efficacy
11.
Texto & contexto enferm ; 31: e20200525, 2022. tab
Article in English | LILACS, BDENF | ID: biblio-1357477

ABSTRACT

ABSTRACT Objective: determining the multidimensional factors associated with the severity of chronic back pain is essential to design appropriate interventions. The objective of this study was to assess the physical and emotional factors associated with the severity of chronic back pain in adults. Method: a descriptive, analytical and cross-sectional study, carried out between November 2017 and December 2018 in Family Health Strategies, with 198 adults with chronic back pain. Pain severity, assessed by the Brief Pain Inventory, was considered the outcome variable; and the pain interference in daily activities (Brief Pain Inventory), physical disability (Roland Morris Disability Questionnaire), quality of life (World Health Organization Quality of Life-Brief) and pain threshold (digital algometer) variables were considered explanatory. A Multivariate Multiple Linear Regression analysis, using the stepwise method with 5% significance, was preformed to establish an explanatory model of pain severity. Results: the mean age was 48.03 years old (standard deviation: 12.41). Most of the participants were women, married and worked. The variables that had a significant and joint impact on pain severity were pain interference in daily activities (parameter: 0.196; p-value<0.001) and in mood (parameter: 0.054; p-value=0.039) and physical domain of quality of life (parameter: -0.032; p-value<0.001). Conclusion: physical factors (pain interference in daily activities and physical domain of quality of life) and emotional factors (pain interference in mood) play an important role in the severity of chronic back pain, which reinforces its multidimensional character.


RESUMEN Objetivo: determinar los factores multidimensionales asociados a la gravedad del dolor de espalda crónico es esencial para diseñar intervenciones apropiadas. El objetivo de este estudio fue evaluar los factores físicos y emocionales asociados a la gravedad del dolor de espalda crónico en adultos. Método: estudio descriptivo y analítico, de corte transversal, realizado entre noviembre de 2017 y diciembre de 2018, en unidades de la Estrategia de Salud Familiar, con 198 adultos que sufren dolor de espalda crónico. La gravedad del dolor, evaluada por medio del Brief Pain Inventory, se consideró como variable de resultado; y las variables interferencia del dolor en las actividades cotidianas (Brief Pain Inventory), discapacidad física (Cuestionario de Discapacidad de Roland Morris), calidad de vida (World Health Organization Quality of Life-Brief) y umbral de dolor (algómetro digital) se consideraron como variables explicativas. Se realizó un análisis multivariado de Regresión Lineal Múltiple, usando el método stepwise con 5% de significancia, para establecer el modelo explicativo de la gravedad del dolor. Resultados: la media de edad fue de 48,03 años (desviación estándar: 12,41). La mayoría de los participantes fueron mujeres, casadas y con alguna actividad laboral. Las variables que ejercieron un impacto sobre la gravedad del dolor en forma significativa y conjunta fueron las siguientes: interferencia del dolor en las actividades cotidianas (parámetro: 0,196; valor p<0,001) y en el estado de ánimo (parámetro: 0,054; valor p=0,039) y el dominio físico de la calidad de vida (parámetro: -0,032; valor p<0,001). Conclusión: los factores físicos (interferencia del dolor en las actividades cotidianas y el dominio físico de la calidad de vida) y emocionales (interferencia del dolor en el estado de ánimo) desempeñan un rol importante en la gravedad del dolor de espalda crónico, lo que refuerza su carácter multidimensional.


RESUMO Objetivo: determinar os fatores multidimensionais associados à severidade da dor crônica nas costas é essencial para traçar intervenções apropriadas. O objetivo deste estudo consistiu em avaliar os fatores físicos e emocionais associados à severidade da dor crônica nas costas em adultos. Método: estudo descritivo analítico, de corte transversal, realizado entre novembro de 2017 e dezembro de 2018, em Estratégias de Saúde da Família, com 198 adultos com dor crônica nas costas. A severidade da dor, avaliada pelo Brief Pain Inventory, foi considera variável de desfecho; as variáveis interferência da dor nas atividades cotidianas (Brief Pain Inventory), incapacidade física (Questionário de Incapacidade de Rolland Morris), qualidade de vida (World Health Organization Quality of Life-Brief) e limiar de dor (algômetro digital) foram consideradas variáveis explicativas. Análise multivariada de Regressão Linear Múltipla, usando o método stepwise com 5% de significância, foi conduzida para estabelecer modelo explicativo da severidade da dor. Resultados: a média de idade foi de 48,03 anos (desvio padrão: 12,41). A maioria eram mulheres, casadas e que trabalhavam. As variáveis que tiveram impacto na severidade da dor de forma significativa e conjunta foram interferência da dor nas atividades cotidianas (parâmetro: 0,196; valor p<0,001) e no humor (parâmetro: 0,054; valor p=0,039) e domínio físico da qualidade de vida (parâmetro: -0,032; valor p<0,001). Conclusão: fatores físicos (interferência da dor nas atividades cotidianas e domínio físico da qualidade de vida) e emocionais (interferência da dor no humor) desempenham importante papel na severidade da dor crônica nas costas, o que reforça o seu caráter multidimensional.


Subject(s)
Humans , Pain Measurement , Regression Analysis , Back Pain , Chronic Pain , Activities of Daily Living , Cross-Sectional Studies , Multivariate Analysis , Nursing , National Health Strategies
12.
Actual. osteol ; 18(1): 29-39, 2022. ilus, tab
Article in Spanish | LILACS, BINACIS, UNISALUD | ID: biblio-1395951

ABSTRACT

La osteoporosis es una enfermedad sistémica que deteriora la calidad del hueso y su arquitectura. Como consecuencia, predispone a fracturas por fragilidad, entre las cuales las fracturas vertebrales son frecuentes. Estas se asocian a una gran morbimortalidad. La vertebroplastia ha surgido en 1984 como alter-nativa terapéutica para tratar algunos tumores vertebrales y fracturas vertebrales osteoporóticas dolorosas. Este procedimiento consiste en la inyección de cemento guiado por imágenes, para estabilizar la vértebra fracturada y disminuir el dolor. La vertebroplastia puede ser realizada con anestesia local, sedación o anestesia general. La fuga de cemento fuera de la vértebra es una complicación común; sin embargo esto no suele tener traducción clínica y solamente se trata de un hallazgo imagenológico. En este artículo revisaremos las indicaciones, contraindicaciones, la eficacia, controversias y las complicaciones de la vertebroplastia percutánea. (AU)


Osteoporosis is a systemic disease characterized by bone quality deterioration. As a consequence of this deterioration, osteoporosis results in high fracture risk due to bone fragility. Fractures to the spine are common in this scenario, and relate to an increased morbi-mortality. Vertebroplasty emerged in 1984 as an alternative to treat painful vertebral tumors and osteoporotic vertebral fractures. This procedure relies on image guided cement injection to achieve pain relief and strengthen the vertebral body. Vertebroplasty can be performed under local anesthesia, mild sedation, or general anesthesia. Among its complications, cement leakage is common but it is rarely associated with any symptoms and it is usually an imaging finding. In this article, we will review indications and contraindications, effectiveness, controversies and complications related to percutaneous vertebroplasty. (AU)


Subject(s)
Humans , Male , Female , Middle Aged , Aged , Aged, 80 and over , Spinal Fractures/therapy , Vertebroplasty/methods , Osteoporotic Fractures/therapy , Chronic Pain/therapy , Administration, Cutaneous , Spinal Fractures/classification , Treatment Outcome , Vertebroplasty/adverse effects , Osteoporotic Fractures/classification
13.
Article in English, Portuguese | LILACS, BDENF | ID: biblio-1398833

ABSTRACT

Objetivo: apresentar o estado da arte das publicações expressas na literatura cientifica mundial sobre a temática, bem como identificar os benefícios terapêuticos da Cannabis medicinal no tratamento dos sintomas das doenças neurodegenerativas especificamente doenças de Parkinson, esclerose múltipla e Alzheimer. Método: trata-se de uma revisão integrativa da literatura, cuja busca de dados foi realizada nas bibliotecas virtuais. Web of Science, Scopus, Medline, Lilacs, Cochrane Library e Scielo no período de agosto a outubro de 2021. Resultados: foram encontrados 158 artigos. Vinte e tres artigos foram selecionados para serem lidos na íntegra e 8 atenderam aos critérios desta revisão. Conclusão: as evidências mostram que embora cada vez mais prescritos ou autorizados, a cannabis medicinal ou os Canabinóides para a doenças neurodegenerativas continuam a ser controversos para muitos médicos.


Objective: to present the state of the art of publications expressed in the world Scientific literature on the subject, as well as to identify the therapeutic benefits of medicinal cannabis in the treatment of neurodegenerative diseases, specifically, Parkinson's diseases, multiple sclerosis and Alzheimer's. Method: this is an integrative literature review, whose data search was performed in virtual librares. Web of Science, Scopus, Medline, Lilacs, Cochrane Library and Scielo from August to October 2021. Results:158 articles were found. Twenty-three articles were selected to be read in full and 8 met the criteria of this review. Conclusion: evidence shows that although increasingly prescribed or authorized, medical cannabis or Cannabinoids for chronic pain remain controversial for many physicians.


Objetivo: presentar el estado del arte de las publicaciones expresadas en la literatura científica mundial sobre el tema, así como identificar los beneficios terapéuticos del cannabis medicinal en el tratamiento de enfermedades neurodegenerativas, en concreto, las enfermedades de Parkinson, la esclerosis múltiple y el Alzheimer. Método: se trata de una revisión integradora de la literatura, cuya búsqueda de datos se realizó en bibliotecas virtuales. Web of Science, Scopus, Medline, Lilacs, Cochrane Library y Scielo de agosto a octubre de 2021. Resultados: se encontraron 158 artículos. Se seleccionaron veintitrés artículos para ser leídos en su totalidad y ocho cumplieron los criterios de esta revisión. Conclusión: la evidencia muestra que, aunque cada vez más se prescribe o autoriza, el cannabis medicinal o los cannabinoides para el dolor crónico siguen siendo controvertidos para muchos médicos.


Subject(s)
Humans , Male , Female , Cannabinoids/therapeutic use , Cannabis/drug effects , Neurodegenerative Diseases/drug therapy , Medical Marijuana , Parkinson Disease/therapy , Chronic Pain/therapy , Multiple Sclerosis/therapy
14.
Article in English, Portuguese | LILACS, BDENF | ID: biblio-1398946

ABSTRACT

Objetivo: apresentar o estado da arte das publicações expressas na literatura cientifica mundial sobre a temática, bem como identificar os benefícios terapêuticos da Cannabis medicinal no tratamento da dor. Método: trata-se de uma revisão integrativa da literatura, cuja busca de dados foi realizada nas bibliotecas virtuais. Web of Science, Scopus, Medline, IBECS, Lilacs, Cochrane Library, Emerald Insight e Scielo no período de agosto a outubro de 2021. Resultados: foram encontrados 367 artigos. Quarenta e três artigos foram selecionados para serem lidos na íntegra e 15 atenderam aos critérios desta revisão. Conclusão: as evidências mostram que embora cada vez mais prescritos ou autorizados, a cannabis medicinal ou os Canabinóides para a dor crónica continuam a ser controversos para muitos médicos.


Objective: to present the state of the art of publications expressed in the world scientific literature on the subject, as well as to identify the therapeutic benefits of medicinal cannabis in the treatment of pain. Method: this is an integrative literature review, whose data search was performed in virtual libraries. Web of Science, Scopus, Medline, IBECS, Lilacs, Cochrane Library, Emerald Insight and Scielo from August to October 2021. Results: 367 articles were found. Forty-three articles were selected to be read in full and 15 met the criteria of this review. Conclusion: evidence shows that although increasingly prescribed or authorized, medical cannabis or Cannabinoids for chronic pain remain controversial for many physicians.


Objetivo: presentar el estado del arte de las publicaciones expresadas en la literatura científica mundial sobre el tema, así como identificar los beneficios terapéuticos del cannabis medicinal en el tratamiento del dolor. Método: se trata de una revisión integradora de la literatura, cuya búsqueda de datos se realizó en bibliotecas virtuales. Web of Science, Scopus, Medline, IBECS, Lilacs, Cochrane Library, Emerald Insight y Scielo de agosto a octubre de 2021. Resultados: se encontraron 367 artículos. Se seleccionaron 43 artículos para ser leídos en su totalidad y 15 cumplieron con los criterios de esta revisión. Conclusión: la evidencia muestra que, aunque cada vez más se prescribe o autoriza, el cannabis medicinal o los cannabinoides para el dolor crónico siguen siendo controvertidos para muchos médicos.


Subject(s)
Humans , Male , Female , Cannabinoids/therapeutic use , Chronic Pain/therapy , Medical Marijuana/therapeutic use , Neoplasms/therapy , Cannabis/drug effects
15.
Evid. actual. práct. ambul ; 25(3): e007030, 2022. ilus, tab
Article in Spanish | LILACS, BINACIS, UNISALUD | ID: biblio-1398071

ABSTRACT

Introducción. Desde hace varios años, el abordaje de los pacientes adultos mayores que consultan por dolor crónico en un centro periférico del Hospital Italiano del conurbano bonaerense se realiza de manera integral, mediante la evaluación conjunta de una kinesióloga y un médico de familia, lo que facilita la indicación terapéutica individualizada, con la aplicación de estrategias cognitivo-conductuales. Objetivo. Documentar los resultados clínicos luego de una evaluación integral de pacientes mayores de 60 años que consultaron por dolor crónico de columna refractarios a tratamientos monodisciplinarios. Métodos. Estudio observacional, analítico tipo antes-después, prospectivo. Recolectamos variables descriptivas de los participantes al momento de la evaluación integral (demográficas, antropométricas, contextuales y clínicas) y de desenlace: dolor, calidad de vida y actividad física a los tres y seis meses, consultas no programadas y a servicio de traumatología durante ese periodo. Estimamos necesaria una muestra de 30 pacientes, pero debido a la pandemia por SARS-CoV-2finalizamos precozmente el estudio con los pacientes reclutados hasta ese momento. Resultados. Incluimos nueve participantes (edad media 66,5 años, desviación estándar 4,9; 67 % sexo femenino). Todos completaron el seguimiento a seis meses. Observamos reducción del dolor y mejoría de la calidad de vida a los seis meses (cambio en la escala visual analógica [EVA] -3, intervalo de confianza [IC] 95 % -5,1 a -0,94; cambio en el puntaje del EQ-5D-3L 0,17, IC 95 % 0,08 a 0,26, respectivamente). Conclusión. En los pacientes adultos mayores de 60 años con dolor crónico de columna no oncológico evaluados de manera integral por un médico de familia y un kinesiólogo se observó una mejoría del dolor y la calidad de vida a los seis meses de seguimiento. Debido a que el diseño no incluyó un grupo control estas diferencias no pueden atribuirse de manera fehaciente a la intervención, aunque estos hallazgos son concordantes con los de ensayos previos. (AU)


Introduction. For several years, the approach of elderly patients who consult for chronic pain in a peripheral center ofthe Hospital Italiano de Buenos Aires has been carried out in a comprehensive way, through the joint evaluation of akinesiologist and a family doctor, which facilitates individualized therapeutic indication, with the application of cognitive-behavioral strategies.Objective. To document the clinical results after the comprehensive evaluation of patients over 60 years of age whoconsulted for chronic back pain refractory to monodisciplinary treatments. Methods. Observational, analytical, before-after, prospective study. We collected descriptive variables from the participantsat the time of the comprehensive evaluation (demographic, anthropometric, contextual and clinical) and outcome variables:pain, quality of life and physical activity at three and six months, unscheduled consultations and trauma service during thatperiod. We estimate that a sample of 30 patients is necessary, but due to the SARS-CoV-2 pandemic we ended the studyearly with the patients recruited up to that time. Results. We included nine participants (mean age 66.5 years, standard deviation 4.9; 67 % female). All completed the six-month follow-up. We observed reduction in pain and improvement in quality of life at six months (change in visual analogscale [VAS] -3, 95 % confidence interval [CI] -5.1 to -0.94; change in score of the EQ-5D-3L 0.17, 95 % CI 0.08 to 0.26,respectively). Conclusion. In adult patients over 60 years of age with chronic non-cancer back pain who were comprehensively evaluatedby a family doctor and a kinesiologist, an improvement in pain and quality of life was observed at six months of follow-up. Since the design did not include a control group, these differences cannot be reliably attributed to the intervention, althoughthese findings are consistent with those of previous trials. (AU)


Subject(s)
Humans , Male , Female , Middle Aged , Aged , Patient Care Team/statistics & numerical data , Low Back Pain/therapy , Back Pain/therapy , Comprehensive Health Care/statistics & numerical data , Chronic Pain/therapy , Pain Management/statistics & numerical data , Argentina , Quality of Life , Exercise , Treatment Outcome , Social Factors
16.
Article in Chinese | WPRIM | ID: wpr-936306

ABSTRACT

OBJECTIVE@#To investigate the inhibitory effect of ANA-12 that blocks brain-derived neurotrophic factor (BDNF)/ tropomyosin receptor kinase B (TrkB) signaling on inflammatory pain in rats and explore the underlying mechanism.@*METHODS@#Forty-two adult SD rats were randomized into BDNF-induced acute pain group (n=24) and CFA-induced chronic pain group. The former group were randomly divided into 4 subgroups, including a control group, ANA-12 treatment group, BDNF treatment group, and BDNF+ANA-12 treatment group; the latter group were subgrouped into control group, CFA treatment group (CFA) and CFA + ANA-12 treatment group. The effects of ANA-12 treatment on pain behaviors of the rats with BDNF-induced acute pain and CFA-induced chronic inflammatory pain were observed. Western blotting was used to examine TrkB signaling and expressions of microglia marker protein Iba1 and TNF-α in the spinal cord of the rats.@*RESULTS@#BDNF injection into the subarachnoid space significantly increased the number of spontaneous paw withdrawal of the rats (P < 0.05), which was obviously reduced by ANA-12 treatment (P < 0.05). The rats with intraplantar injection of CFA, showed significantly increased ipsilateral mechanical stimulation sensitivity (P < 0.05), and ANA-12 treatment obviously increased the ipsilateral foot withdrawal threshold (P < 0.05). Treatment with either BDNF or CFA significantly increased the phosphorylation level of TrkB (Y705) in the spinal cord of the rats (P < 0.05), which was significantly lowered by ANA-12 treatment (P < 0.05). Treatment with BDNF and CFA both significantly up-regulated the expressions of Iba1 and TNF-α in the spinal cord (P < 0.05), but ANA-12 significantly reduced their expression levels (P < 0.05).@*CONCLUSION@#ANA-12 can reduce spinal cord inflammation and relieve acute and chronic pain in rats by targeted blocking of BDNF/TrkB signaling.


Subject(s)
Animals , Brain-Derived Neurotrophic Factor/metabolism , Chronic Pain/drug therapy , Inflammation , Rats , Rats, Sprague-Dawley , Receptor, trkB/metabolism
17.
Journal of Integrative Medicine ; (12): 135-144, 2022.
Article in English | WPRIM | ID: wpr-929211

ABSTRACT

BACKGROUND@#Beginning with the concepts of stress developed by Selye, an approach to stress and pain management, known as neuro-emotional technique (NET), has been developed. It is a treatment approach based on the principle that the stressor effects of dormant and/or current unresolved issues or trauma are what determine one's bodily responses. These responses are relatively personalized to the conditioned, experiential and emotional reality of the individual.@*OBJECTIVE@#To determine the effect of NET on patients with chronic low back pain (CLBP) over time.@*DESIGN, SETTING, PARTICIPANTS, AND INTERVENTIONS@#In a randomized, double-blinded, placebo-controlled study conducted in a single clinic, NET or control treatments were given twice weekly for 4 weeks in a population of 112 patients.@*MAIN OUTCOME MEASURES@#Outcome measures, including Oswestry Disability Index, Quadruple Visual Analogue Scale, the psychoneuroimmunology markers of blood serum levels of C-reactive protein, tumour necrosis factor-α, interleukin-1 (IL-1), IL-6, and IL-10, and 10 dimensions of the Short Form Health Survey scale, were assessed at baseline and at 1, 3 and 6 months following the intervention period.@*RESULTS@#Compared to placebo, NET produced clinical and statistical significance (P < 0.001) via declines of virtually all physiological, pain and disability markers, accompanied by gains in quality-of-life indicators at 0 (baseline), 1, 3 and 6 months. Reductions of the percentages of patients whose 5 biomarkers lay outside the normative range were achieved at 1, 3 and 6 months by NET but not control interventions.@*CONCLUSION@#A randomized, controlled trial of CLBP patients indicated that 8 NET interventions, compared to placebo, produced clinically and statistically significant reductions in pain, disability and inflammatory biomarkers, and improvements in quality-of-life measures.@*TRIAL REGISTRATION@#The trial was registered with the Australian and New Zealand Clinical Trials Registry (No. ACTRN12608000002381).


Subject(s)
Australia , Chronic Pain/therapy , Double-Blind Method , Humans , Low Back Pain/therapy , Pain Measurement , Treatment Outcome
18.
Neuroscience Bulletin ; (6): 440-452, 2022.
Article in English | WPRIM | ID: wpr-929115

ABSTRACT

Pain is an unpleasant sensory and emotional experience associated with, or resembling that associated with, actual or potential tissue damage. The processing of pain involves complicated modulation at the levels of the periphery, spinal cord, and brain. The pathogenesis of chronic pain is still not fully understood, which makes the clinical treatment challenging. Optogenetics, which combines optical and genetic technologies, can precisely intervene in the activity of specific groups of neurons and elements of the related circuits. Taking advantage of optogenetics, researchers have achieved a body of new findings that shed light on the cellular and circuit mechanisms of pain transmission, pain modulation, and chronic pain both in the periphery and the central nervous system. In this review, we summarize recent findings in pain research using optogenetic approaches and discuss their significance in understanding the pathogenesis of chronic pain.


Subject(s)
Brain , Chronic Pain , Humans , Neurons , Optogenetics , Spinal Cord
19.
Neuroscience Bulletin ; (6): 342-358, 2022.
Article in English | WPRIM | ID: wpr-929097

ABSTRACT

Central sensitization is essential in maintaining chronic pain induced by chronic pancreatitis (CP), but cortical modulation of painful CP remains elusive. Here, we examined the role of the anterior cingulate cortex (ACC) in the pathogenesis of abdominal hyperalgesia in a rat model of CP induced by intraductal administration of trinitrobenzene sulfonic acid (TNBS). TNBS treatment resulted in long-term abdominal hyperalgesia and anxiety in rats. Morphological data indicated that painful CP induced a significant increase in FOS-expressing neurons in the nucleus tractus solitarii (NTS) and ACC, and some FOS-expressing neurons in the NTS projected to the ACC. In addition, a larger portion of ascending fibers from the NTS innervated pyramidal neurons, the neural subpopulation primarily expressing FOS under the condition of painful CP, rather than GABAergic neurons within the ACC. CP rats showed increased expression of vesicular glutamate transporter 1, and increased membrane trafficking and phosphorylation of the N-methyl-D-aspartate receptor (NMDAR) subunit NR2B and the α-amino-3-hydroxy-5-methyl-4-isoxazole propionic acid receptor (AMPAR) subunit GluR1 within the ACC. Microinjection of NMDAR and AMPAR antagonists into the ACC to block excitatory synaptic transmission significantly attenuated abdominal hyperalgesia in CP rats, which was similar to the analgesic effect of endomorphins injected into the ACC. Specifically inhibiting the excitability of ACC pyramidal cells via chemogenetics reduced both hyperalgesia and comorbid anxiety, whereas activating these neurons via optogenetics failed to aggravate hyperalgesia and anxiety in CP rats. Taken together, these findings provide neurocircuit, biochemical, and behavioral evidence for involvement of the ACC in hyperalgesia and anxiety in CP rats, as well as novel insights into the cortical modulation of painful CP, and highlights the ACC as a potential target for neuromodulatory interventions in the treatment of painful CP.


Subject(s)
Animals , Anxiety/etiology , Chronic Pain/etiology , GABAergic Neurons , Gyrus Cinguli/metabolism , Hyperalgesia/metabolism , Pancreatitis, Chronic/pathology , Rats , Rats, Sprague-Dawley , Receptors, N-Methyl-D-Aspartate/metabolism , Trinitrobenzenesulfonic Acid/toxicity
20.
Asian Journal of Andrology ; (6): 323-331, 2022.
Article in English | WPRIM | ID: wpr-928541

ABSTRACT

We investigated the therapeutic effects of superoxide dismutase (SOD) from thermophilic bacterium HB27 on chronic prostatitis/chronic pelvic pain syndrome (CP/CPPS) and its underlying mechanisms. A Sprague-Dawley rat model of CP/CPPS was prepared and then administered saline or Thermus thermophilic (Tt)-SOD intragastrically for 4 weeks. Prostate inflammation and fibrosis were analyzed by hematoxylin and eosin staining, and Masson staining. Alanine transaminase (ALT), aspartate transaminase (AST), serum creatinine (CR), and blood urea nitrogen (BUN) levels were assayed for all animals. Enzyme-linked immunosorbent assays (ELISA) were performed to analyze serum cytokine concentrations and tissue levels of malondialdehyde, nitric oxide, SOD, catalase, and glutathione peroxidase. Reactive oxygen species levels were detected using dichlorofluorescein diacetate. The messenger ribonucleic acid (mRNA) expression of tissue cytokines was analyzed by reverse transcription polymerase chain reaction (RT-PCR), and infiltrating inflammatory cells were examined using immunohistochemistry. Nuclear factor-κB (NF-κB) P65, P38, and inhibitor of nuclear factor-κBα (I-κBα) protein levels were determined using western blot. Tt-SOD significantly improved histopathological changes in CP/CPPS, reduced inflammatory cell infiltration and fibrosis, increased pain threshold, and reduced the prostate index. Tt-SOD treatment showed no significant effect on ALT, AST, CR, or BUN levels. Furthermore, Tt-SOD reduced inflammatory cytokine expression in prostate tissue and increased antioxidant capacity. This anti-inflammatory activity correlated with decreases in the abundance of cluster of differentiation 3 (CD3), cluster of differentiation 45 (CD45), and macrophage inflammatory protein 1α (MIP1α) cells. Tt-SOD alleviated inflammation and oxidative stress by reducing NF-κB P65 and P38 protein levels and increasing I-κBα protein levels. These findings support Tt-SOD as a potential drug for CP/CPPS.


Subject(s)
Animals , Chronic Pain , Cytokines/metabolism , Fibrosis , Humans , Inflammation/metabolism , Male , NF-kappa B/metabolism , Pelvic Pain/pathology , Prostatitis/metabolism , Rats , Rats, Sprague-Dawley , Superoxide Dismutase , Syndrome
SELECTION OF CITATIONS
SEARCH DETAIL